We are live on
!
Find out more
ED
Exane Derivatives Portfolio holdings
AUM
$174M
1-Year Est. Return
7.84%
This Fund
S&P 500
This Quarter
Est. Return
+23.79%
1 Year Est. Return
-7.84%
3 Year Est. Return
+42.72%
5 Year Est. Return
+56.28%
10 Year Est. Return
–
AUM
$340M
AUM Growth
-$5.31M
(-1.5%)
Cap. Flow
-$33M
Cap. Flow
% of AUM
-9.71%
Top 10 Holdings %
Top 10 Hldgs %
23.05%
Holding
889
New
138
Increased
211
Reduced
255
Closed
64
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Stellantis
STLA
|
+$10.1M |
| 2 |
Vale
VALE
|
+$2.39M |
| 3 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$2.33M |
| 4 |
Coca-Cola
KO
|
+$2.2M |
| 5 |
Wells Fargo
WFC
|
+$1.58M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street Energy Select Sector SPDR ETF
XLE
|
+$13.6M |
| 2 |
iShares MSCI Turkey ETF
TUR
|
+$7.85M |
| 3 |
iShares MSCI Taiwan ETF
EWT
|
+$6.97M |
| 4 |
Logitech
LOGI
|
+$5.93M |
| 5 |
UBS Group
UBS
|
+$5.5M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Consumer Discretionary | 15.45% |
| 2 | Technology | 13.37% |
| 3 | Healthcare | 13.11% |
| 4 | Financials | 10.95% |
| 5 | Communication Services | 7.14% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
251
Viking Therapeutics
VKTX
$3.84B
| $289K | 0.08% |
51,284
+6,407
| +14% | +$38.8K |
|
252
Qorvo
QRVO
$8.01B
| $288K | 0.08% |
1,735
+829
| +92% | +$122K |
|
253
AB InBev
BUD
$166B
| $285K | 0.08% |
4,077
+3,427
| +527% | +$217K |
|
|
TCF
254
DELISTED
TCF Financial Corporation Common Stock
TCF
| $282K | 0.08% |
7,614
+2,596
| +52% | +$82.5K |
|
255
American Airlines Group
AAL
$10.2B
| $282K | 0.08% |
17,856
+2,606
| +17% | +$36.1K |
|
256
Illumina
ILMN
$31B
| $281K | 0.08% |
781
-744
| -49% | -$237K |
|
257
Vanguard Morningstar Value ETF
VTV
$188B
| $280K | 0.08% |
+2,350
| New | +$264K |
|
258
NextEra Energy
NEE
$183B
| $276K | 0.08% |
+3,575
| New | +$267K |
|
259
Ericsson
ERIC
$32.1B
| $274K | 0.08% |
22,922
+8,256
| +56% | +$96.7K |
|
|
BZUN
260
Baozun
BZUN
$173M
| $269K | 0.08% |
7,844
-11,373
| -59% | -$417K |
|
261
VanEck Video Gaming and eSports ETF
ESPO
$253M
| $266K | 0.08% |
3,800
| – | – |
|
262
Advanced Energy
AEIS
$11B
| $266K | 0.08% |
2,739
+1,368
| +100% | +$116K |
|
|
AMED
263
DELISTED
Amedisys
AMED
| $265K | 0.08% |
903
+539
| +148% | +$138K |
|
264
iShares TIPS Bond ETF
TIP
$14.5B
| $264K | 0.08% |
2,071
-344
| -14% | -$43.4K |
|
265
Moderna
MRNA
$23B
| $264K | 0.08% |
2,528
+178
| +8% | +$18K |
|
266
Dropbox
DBX
$7.49B
| $262K | 0.08% |
11,810
-3,272
| -22% | -$66.6K |
|
|
NIU
267
Niu Technologies
NIU
$203M
| $262K | 0.08% |
9,335
+1,101
| +13% | +$31.9K |
|
268
Canadian Imperial Bank of Commerce
CM
$108B
| $259K | 0.08% |
6,068
+1,308
| +27% | +$53.3K |
|
269
Saia
SAIA
$9.33B
| $258K | 0.08% |
1,425
+756
| +113% | +$124K |
|
270
Invesco QQQ Trust
QQQ
$450B
| $255K | 0.08% |
814
-49
| -6% | -$14.4K |
|
271
Fiverr
FVRR
$330M
| $255K | 0.08% |
+1,308
| New | +$237K |
|
|
TRHC
272
DELISTED
Tabula Rasa HealthCare, Inc. Common Stock
TRHC
| $255K | 0.07% |
5,947
+3,830
| +181% | +$145K |
|
273
Weibo
WB
$1.99B
| $253K | 0.07% |
6,182
-5,012
| -45% | -$212K |
|
274
ICU Medical
ICUI
$4.21B
| $252K | 0.07% |
1,177
+701
| +147% | +$136K |
|
275
Qualcomm
QCOM
$160B
| $250K | 0.07% |
1,639
-281
| -15% | -$39.1K |
|
Similar funds
PC
TWMP
LPWM
ACM
HWIS
LWM
EW
GDWAM
Exane Derivatives's Q4 2020 Portfolio in Review
As of Q4 2020, Exane Derivatives held 889 positions worth $340M, down 1.5% from $345M the previous quarter. Its ten largest holdings account for 23% of the portfolio.
Exane Derivatives withdrew a net $33M in Q4 2020, closing 64 positions and reducing 255 holdings. Its most notable exit was ProShares S&P 500 Dividend Aristocrats ETF, an estimated $2.55M position sold in full.
By sector, the portfolio is most concentrated in Consumer Discretionary at 15% of assets, up from 8.8% a quarter earlier, followed by Technology and Healthcare.
Against the trend, Exane Derivatives opened a new position in Vale worth $3.01M.
- Exane Derivatives's largest Q4 2020 buy was Vale: 179,430 shares worth $3.01M.
- Exane Derivatives added most to Stellantis in Q4 2020, an estimated $10.1M increase.
- Exane Derivatives's biggest Q4 2020 reduction was State Street Energy Select Sector SPDR ETF, cutting an estimated $13.6M.
- Exane Derivatives fully exited ProShares S&P 500 Dividend Aristocrats ETF in Q4 2020, selling an estimated $2.55M.
- Exane Derivatives's ten largest holdings make up 23% of its $340M portfolio in Q4 2020.
- Exane Derivatives opened 138 new positions and closed 64 in Q4 2020.
- Exane Derivatives's portfolio value fell 1.5% quarter-over-quarter to $340M.
Based on Exane Derivatives's 13F filing for Q4 2020, filed 27 Jan 2021.